UK: New ILAP Will Involve Discussions On ‘Commercial Flexibilities’ For Innovative Products

 
• By Eliza Slawther
  
The new innovative licensing pathway in the UK could see more commercial flexibility for companies (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards